Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
PT2M51S | Video has closed captioning.
2024-12-14T10:39:46+0800

CNBC's Angelica Peebles joins 'Squawk Box' with the latest news.
Aired: 2024-12-14T10:39:46+0800
Buy Now:
Problems Playing Video? | Closed Captioning